Spots Global Cancer Trial Database for colorectal adenocarcinoma
Every month we try and update this database with for colorectal adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma | NCT00165217 | Colorectal Aden... | Capecitabine Thalidomide | 18 Years - | Dana-Farber Cancer Institute | |
| CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors | NCT02757391 | Colorectal Aden... Metastatic Chol... Metastatic Colo... Metastatic Dige... Metastatic Esop... Metastatic Gast... Metastatic Panc... Stage IV Colore... Stage IV Esopha... Stage IV Gastri... Stage IV Pancre... Stage IVA Color... Stage IVB Color... | Adoptive Immuno... Aldesleukin Cyclophosphamid... Laboratory Biom... Pembrolizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Early Detection of Cancer Onset Based on Sensing Field Cancerization at the Organ Level in the Alimentary Tract Using an Integrated Stimulated Raman/Scattering Modality for Endoscopic Real-time in Vivo Measurements | NCT05247346 | Esophageal Aden... Barrett Esophag... Colorectal Aden... Colorectal Poly... Colorectal Neop... Colorectal Aden... Carcinogenesis | SENSITIVE syste... | 18 Years - | University Medical Center Groningen | |
| Colorectal Cancer Umbrella Protocol - Assessment of Targeted Therapies Against Colorectal Cancer (ATTACC Program) Screening Protocol | NCT01196130 | Colorectal Canc... | Cancer Symptom ... Biomarker Testi... | 18 Years - | M.D. Anderson Cancer Center | |
| Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors | NCT03149523 | Colorectal Aden... Hepatic Carcino... Kidney Adenocar... | 18 Years - 80 Years | European Georges Pompidou Hospital | ||
| A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors | NCT04731467 | Solid Tumor Non Small Cell ... Pancreatic Canc... Ovarian Cancer Papillary Thyro... Melanoma Colorectal Aden... | CM-24 and Nivol... CM-24, Nivoluma... CM-24, Nivoluma... Nivolumab, Nab ... Nivolumab and N... | 18 Years - | Purple Biotech Ltd. | |
| DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies | NCT06076811 | Colorectal Neop... Colorectal Canc... Colorectal Aden... Colorectal Canc... Colorectal Canc... Colorectal Canc... | 18 Years - | University of Aarhus | ||
| Predicting Local and Distant Recurrence in T1 Colorectal Cancer | NCT06314971 | Colorectal Canc... Colorectal Neop... Colorectal Aden... Colorectal Canc... Colorectal Neop... Colorectal Canc... | Tw1CE | 18 Years - | City of Hope Medical Center | |
| ImmunoNutrition and Colorectal Adenocarcinoma Surgery - INCAS Study | NCT06134440 | Colorectal Aden... | Impact Oral® | 18 Years - | Istituto Oncologico Veneto IRCCS | |
| FNA Tumor Sampling for CD137 Modulation: A Pilot Study | NCT01114256 | Head and Neck C... Breast Cancer Head and Neck C... Non-Hodgkin Lym... Colorectal Aden... | FNA Biopsy | 21 Years - | Stanford University | |
| Bevacizumab Plus Capecitabin vs S-1 as Maintenance Treatment Following First-line Chemotherapy in the Patients With Advanced Colorectal Adenocarcinoma | NCT03708536 | Colorectal Aden... | S-1 Bevacizumab Capecitabine | 18 Years - 75 Years | Fujian Cancer Hospital | |
| Chemotherapy Sequential Tislelizumab After Radical Resection in Patients With dMMR/MSI-H or POLE/POLD1 Mutations | NCT06118658 | Gastric Colorectal Aden... | tislelizumab | 18 Years - 75 Years | China Medical University, China | |
| Use of iFOBT in Patients Presenting With Alarm Symptoms of Colorectal Cancer | NCT03367611 | Colorectal Neop... Colorectal Canc... Colorectal Carc... Colorectal Aden... Colorectal Aden... | Immunochemical ... | 40 Years - | University of Aarhus | |
| Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas | NCT03715933 | Solid Tumors Malignant Pleur... Gastric Adenoca... Colorectal Aden... Sarcoma Pancreatic Aden... Ewing Sarcoma Chondrosarcoma GIST SDH-deficient S... | INBRX-109 Carboplatin Cisplatin Pemetrexed 5-fluorouracil Irinotecan Temozolomide | 12 Years - 85 Years | Inhibrx Biosciences, Inc | |
| Early Onset Colorectal Cancer Detection | NCT06342401 | Colorectal Canc... Colorectal Neop... Colorectal Aden... Colorectal Canc... Colorectal Canc... Colorectal Canc... Colorectal Canc... Colorectal Neop... | ENCODE | 18 Years - 50 Years | City of Hope Medical Center | |
| Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer | NCT04963283 | Colorectal Aden... Colon Cancer Colon Adenocarc... Rectum Cancer Rectal Cancer Rectal Adenocar... Colorectal Canc... | Cabozantinib Nivolumab | 18 Years - | University of Colorado, Denver | |
| Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma | NCT01639131 | Metastatic Colo... | Gemcitabine Docetaxel Filgrastim or P... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors | NCT02650635 | Colorectal Aden... Metastatic Panc... Recurrent Breas... Recurrent Color... Recurrent Melan... Recurrent Non-S... Recurrent Pancr... Recurrent Renal... Solid Neoplasm Stage IV Breast... Stage IV Non-Sm... Stage IV Renal ... Stage IV Skin M... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... | Cyclophosphamid... Laboratory Biom... Pegfilgrastim Pharmacological... TLR8 Agonist VT... | 18 Years - | Mayo Clinic | |
| Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms | NCT03468244 | Advanced Esopha... Gastric Adenoca... Pancreatic Aden... Colorectal Aden... | Personalized mR... | 18 Years - 75 Years | Changhai Hospital | |
| Regorafenib in Metastatic Colorectal Cancer | NCT02466009 | Metastatic Colo... | Regorafenib | 70 Years - | University of Rochester | |
| Performance and Safety of MiWEndo-assisted Colonoscopy (MiWEndo II) | NCT05988645 | Colorectal Canc... Colorectal Poly... Colorectal Aden... Colorectal Aden... Colorectal Aden... Colorectal Neop... | MiWEndo System | 18 Years - | MiWEndo Solutions S.L. | |
| Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery | NCT02292758 | Colorectal Aden... RAS Wild Type Stage IV Colore... Stage IVA Color... Stage IVB Color... | Bevacizumab Cetuximab Irinotecan Laboratory Biom... Placebo | 18 Years - | Academic and Community Cancer Research United | |
| Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma | NCT03376659 | Metastatic Colo... Colorectal Aden... Pancreatic Aden... Metastatic Panc... | Durvalumab CV301 Capecitabine Bevacizumab | 18 Years - | Georgetown University | |
| Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer | NCT00593060 | Colorectal Canc... Colorectal Aden... | Temsirolimus Cetuximab | 18 Years - | Massachusetts General Hospital | |
| Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer | NCT03095781 | Colorectal Aden... Metastatic Panc... Recurrent Color... Recurrent Pancr... Stage III Color... Stage III Pancr... Stage IIIA Colo... Stage IIIB Colo... Stage IV Colore... Stage IV Pancre... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... Unresectable Pa... | XL888 Pembrolizumab | 18 Years - | Emory University | |
| Safety and Feasibility of Electrochemotherapy in Unresectable Colorectal Adenocarninoma Liver Metastases | NCT02709811 | Colorectal Aden... | Electrochemothe... | 18 Years - | IGEA | |
| Colvera for Detection of Disease Recurrence | NCT03706235 | Colorectal Aden... | Blood draw (ven... | 18 Years - | Clinical Genomics Pathology | |
| Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet | NCT04898842 | Colorectal Canc... Colorectal Neop... Colorectal Carc... Colorectal Aden... Colorectal Canc... Ovarian Cancer Ovarian Neoplas... Metastatic Colo... Metastatic Ovar... Peritoneal Carc... Bowel Obstructi... | Dietary interve... | 18 Years - | Royal Surrey County Hospital NHS Foundation Trust | |
| A Pilot Study to Explore the Role of Gut Flora in Colorectal Cancer | NCT04148378 | Colorectal Canc... Colorectal Neop... Colorectal Carc... Colorectal Aden... Colorectal Canc... Colorectal Sarc... | No intervention | - | ProgenaBiome | |
| Study of the Practice of Debiri in France | NCT03369041 | Colorectal Aden... Hepatic Metasta... | Irinotecan-Elut... | 18 Years - 130 Years | Federation Francophone de Cancerologie Digestive | |
| Early-Onset Colorectal Cancer Recurrence | NCT06271980 | Colorectal Canc... Colorectal Canc... Colorectal Neop... Colorectal Aden... Colorectal Canc... Colorectal Canc... Colorectal Canc... | ENCORE | 18 Years - 50 Years | City of Hope Medical Center | |
| Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients | NCT05411133 | Gastrointestina... Cholangiocarcin... Liver Cancer Colorectal Aden... Pancreatic Canc... Gastric Cancer Esophageal Aden... Gastroesophagea... | Cabotamig (ARB2... | 18 Years - | Arbele Limited | |
| Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer | NCT03576963 | Colorectal Aden... CpG Island Meth... Metastatic Micr... Refractory Colo... Stage IV Colore... Stage IVA Color... Stage IVB Color... Stage IVC Color... | Guadecitabine Nivolumab | 18 Years - | University of Southern California | |
| Phase 2 Study of DKN-01 in Colorectal Cancer | NCT05480306 | Colorectal Canc... Colorectal Aden... Colo-rectal Can... Colorectal Canc... | DKN-01 FOLFIRI Bevacizumab FOLFOX | 18 Years - | Leap Therapeutics, Inc. | |
| Early Onset Colorectal Cancer Detection | NCT06342401 | Colorectal Canc... Colorectal Neop... Colorectal Aden... Colorectal Canc... Colorectal Canc... Colorectal Canc... Colorectal Canc... Colorectal Neop... | ENCODE | 18 Years - 50 Years | City of Hope Medical Center | |
| A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors | NCT05731271 | Locally Advance... Metastatic Tumo... Colorectal Aden... | TST003 | 18 Years - | Suzhou Transcenta Therapeutics Co., Ltd. | |
| DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies | NCT06076811 | Colorectal Neop... Colorectal Canc... Colorectal Aden... Colorectal Canc... Colorectal Canc... Colorectal Canc... | 18 Years - | University of Aarhus | ||
| Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus | NCT00597506 | Colorectal Aden... | Bevacizumab Everolimus | 18 Years - | Duke University | |
| Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF | NCT01367275 | Colorectal Canc... Colorectal Aden... | Brivanib Irinotecan | 18 Years - | M.D. Anderson Cancer Center | |
| Safety and Feasibility of Electrochemotherapy in Unresectable Colorectal Adenocarninoma Liver Metastases | NCT02709811 | Colorectal Aden... | Electrochemothe... | 18 Years - | IGEA | |
| Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms | NCT03468244 | Advanced Esopha... Gastric Adenoca... Pancreatic Aden... Colorectal Aden... | Personalized mR... | 18 Years - 75 Years | Changhai Hospital | |
| Feasibility and Safety of MiWEndo-assisted Colonoscopy | NCT05477836 | Colorectal Canc... Colorectal Poly... Colorectal Aden... Colorectal Neop... Colorectal Aden... Colorectal Aden... | MiWEndo-assiste... | 50 Years - | MiWEndo Solutions S.L. | |
| Early Onset Colorectal Cancer Detection | NCT06342401 | Colorectal Canc... Colorectal Neop... Colorectal Aden... Colorectal Canc... Colorectal Canc... Colorectal Canc... Colorectal Canc... Colorectal Neop... | ENCODE | 18 Years - 50 Years | City of Hope Medical Center | |
| Phase 2 Study of DKN-01 in Colorectal Cancer | NCT05480306 | Colorectal Canc... Colorectal Aden... Colo-rectal Can... Colorectal Canc... | DKN-01 FOLFIRI Bevacizumab FOLFOX | 18 Years - | Leap Therapeutics, Inc. | |
| Molecular Determinants of Response to Preoperative Therapy in Patients With Locally Advanced Colorectal Cancer | NCT02877056 | Colorectal Canc... | Endoscopy | 18 Years - | M.D. Anderson Cancer Center | |
| Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer | NCT06225011 | Colorectal Aden... | Fluoxetine | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer | NCT06225011 | Colorectal Aden... | Fluoxetine | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Study of JK08 in Patients With Unresectable Locally Advanced or Metastatic Cancer | NCT05620134 | Cancer Tumor, Solid Advanced Solid ... Metastatic Canc... Melanoma Colorectal Canc... Non-small Cell ... Small-cell Lung... Urothelial Carc... Squamous Cell C... Luminal Breast ... Triple Negative... Clear Cell Rena... Papillary Renal... Gastric Adenoca... GastroEsophagea... Squamous Cell C... Pancreatic Aden... Hepatocellular ... Colorectal Aden... Epithelial Ovar... Thyroid Cancer | JK08 Pembrolizumab | 18 Years - | Salubris Biotherapeutics Inc | |
| To Compare Artificial Intelligence Software Aided Adenoma Detection in Screening Colonoscopies Versus Standard Colonoscopy Without Artificial Intelligence Software Assistance in Participants Between 45 and 75 Years of Age | NCT04196088 | Colorectal Aden... Colorectal Poly... Colorectal Aden... Colorectal SSA | Ultivision Arti... No Artificial I... | 45 Years - 75 Years | Docbot, Inc. | |
| Study of the Practice of Debiri in France | NCT03369041 | Colorectal Aden... Hepatic Metasta... | Irinotecan-Elut... | 18 Years - 130 Years | Federation Francophone de Cancerologie Digestive | |
| Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas | NCT03715933 | Solid Tumors Malignant Pleur... Gastric Adenoca... Colorectal Aden... Sarcoma Pancreatic Aden... Ewing Sarcoma Chondrosarcoma GIST SDH-deficient S... | INBRX-109 Carboplatin Cisplatin Pemetrexed 5-fluorouracil Irinotecan Temozolomide | 12 Years - 85 Years | Inhibrx Biosciences, Inc | |
| Predicting Local and Distant Recurrence in T1 Colorectal Cancer | NCT06314971 | Colorectal Canc... Colorectal Neop... Colorectal Aden... Colorectal Canc... Colorectal Neop... Colorectal Canc... | Tw1CE | 18 Years - | City of Hope Medical Center | |
| Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer | NCT05635149 | Colorectal Aden... | radiotherapy | 18 Years - 75 Years | Wuhan Union Hospital, China | |
| A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors | NCT04731467 | Solid Tumor Non Small Cell ... Pancreatic Canc... Ovarian Cancer Papillary Thyro... Melanoma Colorectal Aden... | CM-24 and Nivol... CM-24, Nivoluma... CM-24, Nivoluma... Nivolumab, Nab ... Nivolumab and N... | 18 Years - | Purple Biotech Ltd. | |
| Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors | NCT03507998 | Colorectal Aden... Gastric Adenoca... Pancreatic Aden... Bile Duct Carci... Hepatocellular ... Esophageal Carc... Gastrointestina... | CGX1321 | 18 Years - | Curegenix Inc. | |
| Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years With a Metastatic Colorectal Adenocarcinoma . | NCT02788006 | Colorectal Aden... | Regorafenib 160... | 70 Years - | Federation Francophone de Cancerologie Digestive | |
| Analysis of Histopathological Factors Predictive of Lymph Node Involvement and Management Practices in pT1 Colorectal Cancers Treated by Primary Endoscopic Resection: a Retrospective Population-based Study (PROMOT1) | NCT06339346 | Colorectal Canc... Colorectal Aden... | - | University Hospital, Brest | ||
| METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin | NCT05504252 | Colorectal Aden... Mucinous Adenoc... Signet Ring Cel... | Nivolumab Oxaliplatin | 18 Years - | University Hospital, Akershus | |
| ImmunoNutrition and Colorectal Adenocarcinoma Surgery - INCAS Study | NCT06134440 | Colorectal Aden... | Impact Oral® | 18 Years - | Istituto Oncologico Veneto IRCCS | |
| Very Low Carbohydrate Diet Effects to GPS, Serum Lactate and TNF Alpha on Colorectal Cancer | NCT03221920 | Diet Modificati... Colorectal Aden... Systemic Inflam... TNF Alpha Lactate | Very Low Carboh... | 18 Years - 65 Years | Dr. Soetomo General Hospital | |
| The Problem of Colorectal Anastomosis Safety | NCT03958500 | Colorectal Canc... Colorectal Carc... Colorectal Neop... Colorectal Aden... | Indocyanine gre... | 18 Years - 100 Years | Vilnius University | |
| Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer | NCT01856322 | Colorectal Canc... Liver Metastasi... Colorectal Aden... | Sulindac Placebo Validate assays... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors | NCT05731271 | Locally Advance... Metastatic Tumo... Colorectal Aden... | TST003 | 18 Years - | Suzhou Transcenta Therapeutics Co., Ltd. | |
| TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors | NCT02650635 | Colorectal Aden... Metastatic Panc... Recurrent Breas... Recurrent Color... Recurrent Melan... Recurrent Non-S... Recurrent Pancr... Recurrent Renal... Solid Neoplasm Stage IV Breast... Stage IV Non-Sm... Stage IV Renal ... Stage IV Skin M... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... | Cyclophosphamid... Laboratory Biom... Pegfilgrastim Pharmacological... TLR8 Agonist VT... | 18 Years - | Mayo Clinic | |
| Vaccine Response With NT-I7 | NCT04054752 | Breast Carcinom... Colorectal Aden... Bladder Carcino... | Recombinant hum... Vaccine sequenc... Vaccine sequenc... | 60 Years - | National Institutes of Health Clinical Center (CC) | |
| Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus | NCT00597506 | Colorectal Aden... | Bevacizumab Everolimus | 18 Years - | Duke University | |
| ImmunoNutrition and Colorectal Adenocarcinoma Surgery - INCAS Study | NCT06134440 | Colorectal Aden... | Impact Oral® | 18 Years - | Istituto Oncologico Veneto IRCCS | |
| The Role of Quantitative Measures on Dual-energy CT in the Prediction of Colorectal Adenocarcinoma | NCT04430127 | Colorectal Aden... | No supplementar... | 20 Years - 80 Years | Hôpital Fribourgeois | |
| Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors | NCT03781778 | Colon Cancer Rectal Cancer Cancer Survivor Colorectal Aden... Stage I Colorec... Stage II Colore... Stage IIA Color... Stage IIB Color... Stage IIC Color... Stage III Color... Stage IIIA Colo... Stage IIIB Colo... Stage IIIC Colo... | Dietary Interve... Dietary Interve... Questionnaire A... | 18 Years - | Fred Hutchinson Cancer Center | |
| A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer | NCT03206073 | Colorectal Canc... Colorectal Carc... Colorectal Aden... Refractory Canc... Colorectal Neop... | Durvalumab Tremelimumab Pexa-Vec Pexa-Vec | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Feasibility and Safety of MiWEndo-assisted Colonoscopy | NCT05477836 | Colorectal Canc... Colorectal Poly... Colorectal Aden... Colorectal Neop... Colorectal Aden... Colorectal Aden... | MiWEndo-assiste... | 50 Years - | MiWEndo Solutions S.L. | |
| Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years With a Metastatic Colorectal Adenocarcinoma . | NCT02788006 | Colorectal Aden... | Regorafenib 160... | 70 Years - | Federation Francophone de Cancerologie Digestive | |
| Early Detection of Advanced Adenomas and Colorectal Cancer | NCT06342440 | Colorectal Canc... Colorectal Neop... Colorectal Poly... Colorectal Aden... Colorectal Diso... Colorectal Dysp... Colorectal Canc... Colorectal Canc... Colorectal Canc... Colorectal Canc... Colorectal Neop... Colorectal Serr... Colorectal Aden... Colorectal Aden... Colorectal Aden... Colorectal Aden... Colorectal Aden... Colorectal Aden... | DENEB | 18 Years - | City of Hope Medical Center | |
| Oncological Impact of Lateral Nodes in Rectal Cancer | NCT05592873 | Colorectal Aden... | Neoadjuvant che... | 18 Years - | Niguarda Hospital | |
| Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer | NCT03095781 | Colorectal Aden... Metastatic Panc... Recurrent Color... Recurrent Pancr... Stage III Color... Stage III Pancr... Stage IIIA Colo... Stage IIIB Colo... Stage IV Colore... Stage IV Pancre... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr... Unresectable Pa... | XL888 Pembrolizumab | 18 Years - | Emory University | |
| Early Detection of Advanced Adenomas and Colorectal Cancer | NCT06342440 | Colorectal Canc... Colorectal Neop... Colorectal Poly... Colorectal Aden... Colorectal Diso... Colorectal Dysp... Colorectal Canc... Colorectal Canc... Colorectal Canc... Colorectal Canc... Colorectal Neop... Colorectal Serr... Colorectal Aden... Colorectal Aden... Colorectal Aden... Colorectal Aden... Colorectal Aden... Colorectal Aden... | DENEB | 18 Years - | City of Hope Medical Center | |
| 5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab | NCT03300609 | Colorectal Aden... RAS Wild Type Stage III Color... Stage IIIA Colo... Stage IIIB Colo... Stage IIIC Colo... Stage IV Colore... Stage IVA Color... Stage IVB Color... | Panitumumab Oxaliplatin Leucovorin Calc... Fluorouracil Capecitabine Quality-of-Life... Laboratory Biom... | 18 Years - | University of Southern California | |
| A Study to Evaluate NT219 Alone and in Combination With ERBITUX® (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer | NCT04474470 | Solid Tumor, Ad... Squamous Cell C... Colorectal Aden... Metastatic Soli... Recurrent Solid... Head and Neck C... | NT219 NT219 and ERBIT... NT219 and ERBIT... | 18 Years - | Purple Biotech Ltd. | |
| Colvera for Detection of Disease Recurrence | NCT03706235 | Colorectal Aden... | Blood draw (ven... | 18 Years - | Clinical Genomics Pathology | |
| Endoscopic Full-Thickness Resection In Colon | NCT03803891 | Colon Neoplasm,... Colo-rectal Can... Colonic Cancer Colonic Adenoma Colorectal Canc... Colorectal Neop... Colorectal Aden... Colon Polyp Colon Lesion Colon Neoplasm | Endoscopic full... | 18 Years - | Fundació Institut Germans Trias i Pujol |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
